Seven Immune-Related Genes’ Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma
Table 1
Comparison of characteristics between TCGA database and the GEO database (GSE27020).
Characteristic
TCGA
GSE27020
Frequency
Deaths (%)
Frequency
Deaths (%)
Total
528
170 (32.20)
109
34 (31.19)
Age (years)
0.063
≤65
345
99 (28.70)
61
19 (31.15)
>65
182
71 (39.01)
48
15 (31.25)
Unknown
1
0
Sex
—
Male
386
114 (29.53)
—
—
Female
142
56 (39.44)
—
—
Grade
0.023
G1-G2
374
120 (32.09)
91
29 (31.87)
G3-G4
132
43 (32.58)
16
5 (31.25)
Unknown
22
7 (31.82)
2
0
Stage
—
Stage I-stage II
120
40 (33.33)
—
—
Stage III-stage IV
394
130 (32.99)
—
—
Unknown
14
0
T
—
T1-T2
189
53 (28.04)
—
—
T3-T4
323
117 (36.22)
—
—
Unknown
16
0
M
—
M0
496
166 (33.47)
—
—
M1
6
3 (50.00)
—
—
Unknown
26
1 (3.85)
N
—
N0
246
88 (35.77)
—
—
N1-N3
260
81 (31.15)
—
—
Unknown
22
1 (4.55)
TCGA: The Cancer Genome Atlas; GEO: Gene Expression Omnibus. Chi-square test for the comparison of characteristics between TCGA database and the GSE27020 database for each clinical variable.
